Edition:
India

Aviragen Therapeutics Inc (AVIR.OQ)

AVIR.OQ on NASDAQ Stock Exchange Capital Market

0.58USD
22 Nov 2017
Change (% chg)

$0.01 (+1.65%)
Prev Close
$0.57
Open
$0.57
Day's High
$0.59
Day's Low
$0.55
Volume
47,626
Avg. Vol
93,229
52-wk High
$1.58
52-wk Low
$0.44

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.20 June 23 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-17 3 0.67 1.00 0.50 --
Quarter Ending Mar-18 1 4.40 4.40 4.40 2.70
Year Ending Jun-17 3 8.43 9.80 6.20 --
Year Ending Jun-18 1 6.50 6.50 6.50 5.07
Earnings (per share)
Quarter Ending Jun-17 2 -0.20 -0.17 -0.23 --
Quarter Ending Mar-18 1 0.01 0.01 0.01 -0.23
Year Ending Jun-17 2 -0.81 -0.78 -0.83 --
Year Ending Jun-18 1 -0.32 -0.32 -0.32 -1.07

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.40 0.10 0.30 75.00
Quarter Ending Jun-17 0.67 0.10 0.57 85.00
Quarter Ending Mar-17 2.97 4.90 1.93 65.17
Quarter Ending Dec-16 1.17 3.80 2.63 225.70
Quarter Ending Sep-16 0.57 0.10 0.47 82.35

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-17 0.67 -- -- -- --
Quarter Ending Mar-18 4.40 4.35 4.30 4.30 2.70
Year Ending Jun-17 8.43 -- -- -- --
Year Ending Jun-18 6.50 6.65 5.50 5.50 5.07

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-17 -- -- -- --
Quarter Ending Mar-18 0 0 0 0
Year Ending Jun-17 -- -- -- --
Year Ending Jun-18 0 0 1 0
Earnings